A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline.
메타분석
1/5 보강
[OBJECTIVE] Financial toxicity, characterized by the financial burden and psychological distress associated with cancer treatment, has become a critical issue impacting patient outcomes and quality of
- 연구 설계 systematic review
APA
Jia M, Zhong L, et al. (2026). A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline.. Journal of patient-reported outcomes, 10(1). https://doi.org/10.1186/s41687-026-01042-z
MLA
Jia M, et al.. "A systematic review of financial toxicity measurement instruments for cancer patients based on the COSMIN guideline.." Journal of patient-reported outcomes, vol. 10, no. 1, 2026.
PMID
41857326 ↗
Abstract 한글 요약
[OBJECTIVE] Financial toxicity, characterized by the financial burden and psychological distress associated with cancer treatment, has become a critical issue impacting patient outcomes and quality of life. This study aimed to conduct an updated and comprehensive systematic review to evaluate the methodological quality and measurement properties of financial toxicity measurement instruments for cancer patients, thereby guiding the selection of high-quality tools for future empirical research.
[METHODS] Literature on financial toxicity measurement instruments for cancer patients was retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, CINAHL, Scopus, and Embase databases, with a search range from the inception up to April 16, 2025. Two researchers independently screened the literature and extracted data. The included studies were assessed using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN), and recommendations were formulated based on the quality of evidence and measurement properties.
[RESULTS] A total of eighteen studies were included, involving eight financial toxicity measurement instruments for cancer patients. None of the studies reported measurement error. The Comprehensive Score for Financial Toxicity (COST), Financial Index of Toxicity (FIT), and Subjective Financial Distress Questionnaire (SFDQ) were provisionally recommended for use (Category B), while the other five instruments were not recommended due to insufficient evidence (Category C).
[CONCLUSION] The COST is provisionally recommended for measuring financial toxicity in cancer patients. The methodological quality and measurement properties of existing financial toxicity instruments still require further improvement. Future research should adhere strictly to the COSMIN guideline to validate existing tools or develop new, high-quality instruments with comprehensive evaluations of their measurement properties.
[METHODS] Literature on financial toxicity measurement instruments for cancer patients was retrieved from CNKI, Wanfang, VIP, SinoMed, PubMed, Web of Science, CINAHL, Scopus, and Embase databases, with a search range from the inception up to April 16, 2025. Two researchers independently screened the literature and extracted data. The included studies were assessed using the Consensus-Based Standards for the Selection of Health Measurement Instruments (COSMIN), and recommendations were formulated based on the quality of evidence and measurement properties.
[RESULTS] A total of eighteen studies were included, involving eight financial toxicity measurement instruments for cancer patients. None of the studies reported measurement error. The Comprehensive Score for Financial Toxicity (COST), Financial Index of Toxicity (FIT), and Subjective Financial Distress Questionnaire (SFDQ) were provisionally recommended for use (Category B), while the other five instruments were not recommended due to insufficient evidence (Category C).
[CONCLUSION] The COST is provisionally recommended for measuring financial toxicity in cancer patients. The methodological quality and measurement properties of existing financial toxicity instruments still require further improvement. Future research should adhere strictly to the COSMIN guideline to validate existing tools or develop new, high-quality instruments with comprehensive evaluations of their measurement properties.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Predicting the Efficacy of Breast Cancer Neoadjuvant Chemotherapy Using Ultrasonography and Machine Learning.
- TiO-coated honeycomb-like super-macroporous silica for high-purity extraction of exosomes from human plasma.
- Navigating thyroid cancer complexity: the emerging role of EV-derived non-coding RNAs.
- Anti-colorectal cancer effects of IRX4 and sensitivity studies to oxaliplatin.
- Screening tumor stage-specific candidate neoantigens in thyroid adenocarcinoma using integrated exome and transcriptome sequencing.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Comprehensive analysis of androgen receptor splice variant target gene expression in prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.